Life Sciences and precision medicine are changing the way we think about health problems with a new generation of healthcare delivery which signifies a movement away from a one-size-fits-all approach to medical care, tailoring medical diagnosis and treatment to individual characteristics of patients. The global precision medicine market across major diseases is forecast to grow to £102bn by 2025.
Technologies which are transforming healthcare delivery, accelerated by the COVID-19 pandemic, include mobile and app-based technologies, wearable devices, how public health messages are both rapidly and effectively communicated, and the analysis and interpretation of data.
In 2024, the total medical technology revenue globally is expected be nearly £450bn. This growing sector requires infrastructure, investment, and real estate to meet this growing demand.
With governments across Europe wanting to further support growth in this industry, we look at the example of Glasgow's Living Lab and explore emerging trends and opportunities for investors in the sector. What are the challenges? What are occupiers looking for? How important is the infrastructure? What makes an attractive location? What and where are the opportunities to invest?
Join this time-efficient event, hear the view of market-leading experts from both the public and private sector, and ask your own questions in this LIVE, interactive, online investment briefing.
Attendance is free but registration is essential - please book now to ensure your place.
In partnership with: